Anti-tumour necrosis factor treatment and pregnancy: the way is open

被引：0
|
作者：
Boulman, N. [1 ]
Rimar, D. [1 ]
Rozenbaum, M. [1 ]
Slobodin, G. [2 ]
Younis, S. [1 ]
Rosner, I. [1 ]
机构：
[1] Bnai Zion Med Ctr, Dept Rheumatol, IL-31048 Haifa, Israel
[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2012年 / 30卷 / 03期
关键词：
THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：453 / 453
页数：1
相关论文
共 50 条
  • [1] Reporting the response to anti-tumour necrosis factor treatment
    Volc, S.
    Ghoreschi, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 867 - 868
  • [2] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Rosner, I.
    Haddad, A.
    Boulman, N.
    Feld, J.
    Avshovich, N.
    Slobodin, G.
    Rozenbaum, M.
    RHEUMATOLOGY, 2007, 46 (09) : 1508 - 1508
  • [3] Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy
    Seow, Cynthia H.
    Casteele, Niels Vande
    Panaccione, Remo
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1379 - 1380
  • [4] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Roux, C. H.
    Brocq, O.
    Breuil, V.
    Albert, C.
    Euller-Ziegler, L.
    RHEUMATOLOGY, 2007, 46 (04) : 695 - 698
  • [5] Inflammatory demyelinating events associated with anti-tumour necrosis factor treatment
    Fromont, A.
    Maillefert, J. F.
    Audry, D.
    Moreau, T.
    MULTIPLE SCLEROSIS, 2006, 12 : S80 - S80
  • [6] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [7] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [8] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [9] ANKYLOSING SPONDYLITIS: ANTI-TUMOUR NECROSIS FACTOR AND BEYOND
    Sengupta, Raj
    RHEUMATOLOGY, 2017, 56 : 10 - 10
  • [10] Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
    Hishitani, Y.
    Ogata, A.
    Shima, Y.
    Hirano, T.
    Ebina, K.
    Kunugiza, Y.
    Shi, K.
    Narazaki, M.
    Hagihara, K.
    Tomita, T.
    Yoshikawa, H.
    Tanaka, T.
    Kumanogoh, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 253 - 259
12345